PyInvesting

Market research

016580.KO Whan In Pharm Co.,Ltd

KO KRW Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
186B
P/E ratio
Not available
Analyst target
17000
Dividend yield
3.0%
Beta
0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Whan In Pharm Co.,Ltd is currently in a long term uptrend where the price is trading 24.1% above its 200 day moving average.

From a valuation standpoint, the stock is 81.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.

Whan In Pharm Co.,Ltd's total revenue rose by 14.5% to $44B since the same quarter in the previous year.

Its net income has increased by 52.0% to $5B since the same quarter in the previous year.

Finally, its free cash flow fell by 131.0% to $-3B since the same quarter in the previous year.

Based on the above factors, Whan In Pharm Co.,Ltd gets an overall score of 4/5.